0

Carmustine

PMID: 29999989

Abstract:

No information is available on the use of carmustine during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, especially alkylating agents such as carmustine.[1] The manufacturer recommends that breastfeeding be discontinued during carmustine therapy and for 1 month after the last dose.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP154938-A Carmustine Carmustine 154-93-8 Price
qrcode